INS and type 2 diabetes mellitus: (Morze et al. 2022) Interventional clinical trials have corroborated these findings, demonstrating that dietary BCAA restriction reduces plasma BCAA levels, decreases fasting insulin concentration, and improves insulin sensitivity in both healthy volunteers (Ramzan et al. 2020), and those with type 2 diabetes (Karusheva et al. 2019).